Thanks for sharing, I read this document last night following a share I saw on Linkedin.
Positive report for sure and a nice base case. totally accept the requirements for further cap raises in the future, this offers solid transparency.
So many international players with whopping valuations. 3DA has some significant strengths which hopefully are recognised in the market and by key partners, especially the R&D connection and future potential pipeline.
- Forums
- ASX - By Stock
- 3DA
- 3DA Growth
3DA Growth, page-3
Featured News
Add 3DA (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $236.7M |
Open | High | Low | Value | Volume |
40.0¢ | 40.0¢ | 38.0¢ | $179.9K | 463.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4397 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4397 | 0.380 |
2 | 37960 | 0.365 |
5 | 583093 | 0.360 |
1 | 250000 | 0.355 |
2 | 38571 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 50000 | 1 |
0.395 | 47412 | 2 |
0.400 | 65499 | 2 |
0.410 | 124000 | 4 |
0.420 | 8773 | 2 |
Last trade - 15.32pm 15/11/2024 (20 minute delay) ? |
Featured News
3DA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online